Latest

Lower Respiratory Tract Infection: Symptom Duration and Severity With Oral Prednisolone

Lower Respiratory Tract Infection: Symptom Duration and Severity With Oral Prednisolone

Oral corticosteroids did not reduce symptom severity or duration in patients with lower respiratory tract infections without asthma.

New Biomarker May Enable Selective Antibiotic Use for COPD Exacerbation

New Biomarker May Enable Selective Antibiotic Use for COPD Exacerbation

Researchers hypothosized that increased sputum Gammaproteobacteria:Firmicutes ratio may serve as a biomarker to guide antibiotic treatment in COPD.

Expert Panel Updates Recommendations for Endoscopic Lung Volume Reduction for Emphysema

Expert Panel Updates Recommendations for Endoscopic Lung Volume Reduction for Emphysema

Advanced emphysema may benefit from endoscopic lung reduction treatment.

Reduced Mortality Risk in COPD Linked to Statin Tx

Reduced Mortality Risk in COPD Linked to Statin Tx

People with COPD have been found to benefit from statin therapies, with reduced risk of all-cause and pulmonary-related mortality.

COPD Exacerbations May Be Reduced With Mucolytic Agents

COPD Exacerbations May Be Reduced With Mucolytic Agents

Patients with COPD treated with mucolytic agents for at least 1 year were better protected against exacerbations compared with patients treated with placebo.

Addressing Asthma Exacerbations Via Sputum Eosinophils vs Clinical Symptoms

Addressing Asthma Exacerbations Via Sputum Eosinophils vs Clinical Symptoms

Adults with asthma benefit from tailoring interventions based on sputum eosinophils vs clinical symptoms.

Inappropriate Use of Short Acting Beta Agonists Linked to Adverse Outcomes

Inappropriate Use of Short Acting Beta Agonists Linked to Adverse Outcomes

Researchers analyzed over 2.1 million patient-years' worth of data to determine the impact of short-acting beta agonist use in asthma.

Tezepelumab Tx in Asthma: Does Treatment Reduce Exacerbations?

Tezepelumab Tx in Asthma: Does Treatment Reduce Exacerbations?

Participants received 70 mg of tezepelumab every 4 weeks throughout the study.

Efficacy of Tiotropium in Mild to Moderate COPD Examined

Efficacy of Tiotropium in Mild to Moderate COPD Examined

FEV1 was higher in patients who received tiotropium therapy vs those in the placebo group.

Global Asthma Mortality Rate Reductions at Standstill

Global Asthma Mortality Rate Reductions at Standstill

International trends in asthma mortality are useful for assessing the effect of treatment strategies on the burden of asthma.

Asthma and COPD: Updates on Prevalence, Disability, and Mortality

Asthma and COPD: Updates on Prevalence, Disability, and Mortality

A 2015 update from the 1990 Global Burden of Disease study reveals current prevalence and mortality of asthma and chronic obstructive pulmonary disease.

Diagnostic Accuracy of NICE Asthma Algorithm Poor in Children

Diagnostic Accuracy of NICE Asthma Algorithm Poor in Children

A new algorithm developed by the National Institute for Health and Care Excellence was not useful for diagnosing asthma in children and adolescents.

Steroid-Resistant Asthma: Exploring New Therapeutic Possibilities

Steroid-Resistant Asthma: Exploring New Therapeutic Possibilities

The pathogeneses of steroid insensitivity in severe, steroid-resistant asthma may unlock new potential treatments.

Association Between Asthma and Inflammatory Bowel Disease Examined

Association Between Asthma and Inflammatory Bowel Disease Examined

Asthma is associated with development of inflammatory bowel disease.

Once-Daily Fluticasone Furoate/Vilanterol Reduces Nighttime Asthma Symptoms

Once-Daily Fluticasone Furoate/Vilanterol Reduces Nighttime Asthma Symptoms

Fluticasone furoate and vilanterol combination therapy reduced both daytime and nighttime symptoms in patients with persistent uncontrolled asthma.

Improving Lung Function, QoL in COP With Once-Daily Triple-Tx

Improving Lung Function, QoL in COP With Once-Daily Triple-Tx

Study results showed the benefit of single-inhaler triple therapy vs ICS/LABA therapy in COPD.

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Recent research suggests that perioperative and postoperative pulmonary rehabilitation improves outcomes in patients undergoing thoracic surgery.

Fracture Risk in COPD Increases With Extended Duration of Corticosteroid Use

Fracture Risk in COPD Increases With Extended Duration of Corticosteroid Use

Inhaled corticosteroids for COPD does not increase the risk for fractures when used for short-term periods.

Sputum Eosinophil Levels Correlate With Asthma Severity

Sputum Eosinophil Levels Correlate With Asthma Severity

Elevated sputum eosinophil levels correlate with the severity of clinical outcomes in asthma.

Earlier Reduction of Allergic Response With Omalizumab in Moderate to Severe Allergic Asthma

Earlier Reduction of Allergic Response With Omalizumab in Moderate to Severe Allergic Asthma

A single-center study found that omalizumab led to reductions in allergic response much earlier than previously demonstrated.

Sign Up for Free e-newsletters